USA flag logo/image

An Official Website of the United States Government

DEVELOPMENT OF OPTIMUM CONDITIONS FOR NIMC PRODUCTION

Award Information

Agency:
Department of Health and Human Services
Branch:
N/A
Award ID:
19032
Program Year/Program:
1992 / SBIR
Agency Tracking Number:
19032
Solicitation Year:
N/A
Solicitation Topic Code:
N/A
Solicitation Number:
N/A
Small Business Information
Argus Pharmaceuticals Inc
3400 Research Forest Drive The Woodlands, TX 77381
View profile »
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No
 
Phase 1
Fiscal Year: 1992
Title: DEVELOPMENT OF OPTIMUM CONDITIONS FOR NIMC PRODUCTION
Agency: HHS
Contract: N/A
Award Amount: $49,904.00
 

Abstract:

MITOCHONDRIAL RESPIRATION INHIBITION IN TUMOR CELLS MAY OCCUR IN TWO MANNERS. ONE MECHANISM INVOLVES THE SYNTHESIS OF NITRIC OXIDE (NO) BY MACROPHAGES OR IFN-GAMMA MEDIATED INDUCTION OF NO SYNTHESIS IN TUMOR CELLS. WE HAVE RECENTLY ESTABLISHED A MURINE MACROPHAGE CELL LINE, EA13.5, THAT RELEASES A SOLUBLE MEDIATOR, NIMC, THAT CAUSES TUMOR CELL RESPIRATION INHIBITION INDEPENDENT OF NO PRODUCTION AND INDEPENDENT OF IFN-GAMMA. PHASE I WILL INVOLVE DEVELOPMENT OF OPTIMAL CONDITIONS FOR EA13.5 CELL GROWTH AND PRODUCTION OF NIMC AND ESTABLISHMENT OF A PURIFICATION SCHEME. THE GROWTH AND TRIGGERING OF THE EA13.5 CELLS IN GAS PERMEABLE BAGS AND IN HOLLOW FIBER BIOREACTORS WILL BE EXAMINED; ONE OF THESE BIOREACTOR SYSTEMS WILL BE SELECTED FOR LARGE-SCALE CULTURE BASED ON EASE OF HANDLING, CELL PROLIFERATION AND VIABILITY, AND YIELD OF NIMC. THE CONDITIONS FOR INDUCTION OF NIMC WILL BE OPTIMIZED WITH RESPECT TO MEDIA, SIGNALS FOR INDUCTION, AND KINETICS OF PRODUCTION. PROTEIN PURIFICATION STEPS WILL BE EXAMINED AND OPTIMIZED FOR DESIGN OF A PURIFICATION SCHEME FOR NIMC. THE SUCCESSFL EXECUTION OF PHASE I WILL ENABLE ECONOMICAL PRODUCTION OF SUFFICIENT NIMC FOR LARGE-SCALE PROTEIN PURIFICATION STUDIES, AMINO ACID SEQUENCING, AND DNA PROBE CONSTRUCTION IN PHASE II.

Principal Investigator:

Alan C Hayman
7133671666

Business Contact:

Small Business Information at Submission:

Argus Pharmaceuticals Inc
3400 Research Forest Drive The Woodlands, TX 77381

EIN/Tax ID:
DUNS: N/A
Number of Employees: N/A
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No